• Mission
  • Approach
  • Research
  • About
  • More
    • Mission
    • Approach
    • Research
    • About
  • Mission
  • Approach
  • Research
  • About

About us

Our History

CpG Diagnostics was founded in 2022 and was born from the laboratory of Dr. Bodour Salhia at University Southern California in Los Angeles. Dr Salhia, a cancer survivor, is a distinguished genomic scientist and the interim Chair of the Department of Translational Genomics at USC's Keck School of Medicine. Driven by a fervent commitment to advancing cancer diagnostics, she seamlessly integrated current edge genomics and epigenomics analyses with her extensive expertise in tumorigenesis and tumor biology.

Our Values

At CpG Diagnostics, we are committed to ethical and responsible biotech research and development. We believe in putting patients first, and we are dedicated to developing products that are safe, effective, and accessible.

In the Press

New blood test may detect ovarian cancer early with 91% accuracy

USC researchers develop blood test to screen for early stage ovarian cancer

Cell-Free DNA methylation liquid biopsy discriminates ovarian cancer

Cell-Free DNA methylation liquid biopsy discriminates ovarian cancer

USC researchers develop blood test to screen for early stage ovarian cancer

Cell-Free DNA methylation liquid biopsy discriminates ovarian cancer

Ovarian cancer could be detected early with a new blood test, study says

USC researchers develop blood test to screen for early stage ovarian cancer

USC researchers develop blood test to screen for early stage ovarian cancer

USC researchers develop blood test to screen for early stage ovarian cancer

USC researchers develop blood test to screen for early stage ovarian cancer

USC researchers develop blood test to screen for early stage ovarian cancer

Copyright © 2024 CpG Diagnostics - All Rights Reserved.

Powered by GoDaddy Website Builder